SCHEMBL3237238

SCHEMBL3237238

N#Cc1ccc(C2CCC(=O)CC2)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 2/20 0.46
HRH3 Q9Y5N1 2/20 0.38
ELANE P08246 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GLA P06280 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HIF1A Q16665 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
FASN P49327 1/20 0.36
DGAT1 O75907 1/20 0.35
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35
ACACB O00763 2/20 0.34
SYK P43405 1/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2860558 0.86 KDM4E (0.39) ELANEKDM4EGLAHTTKMT2A
SCHEMBL14045979 0.81 KDM4E (0.50) HRH3KDM4EGLAHTTKMT2A
SCHEMBL22047801 0.79 CHEK1 (0.40) KDM4EGLAHTTKMT2ASMN1; SMN2
SCHEMBL18721893 0.79 ESR2 (0.44) ESR2HRH3ELANEKDM4EGLA
Hydrochloric Acid SCHEMBL12489003 0.77 CHEK1 (0.49) DDB1CRBNCHEK1SLC6A3KCNH2
SCHEMBL12686799 0.76 FASN (0.39) HRH3FASNCHEK1SLC6A3KCNH2
SCHEMBL13470580 0.76 FASN (0.39) HRH3FASNPDE4BCHEK1PANK3
SCHEMBL3555307 0.76 CHEK1 (0.33) HRH3ELANEKDM4EGLAHTT
SCHEMBL29989 0.75 ACACB (0.38) FASNACACBCHEK1CYP2C9PANK3
SCHEMBL12489379 0.75 FASN (0.47) KDM4EGLAHTTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020108579-A1 AMINO-SUBSTITUTED PYRIDONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF 上海海雁医药科技有限公司 2020-06-04 WO disclosed
US-8637576-B2 Benzamide derivatives and uses related thereto AMGEN INC. (US) 2014-01-28 US disclosed
EP-1904435-B1 BENZAMIDE DERIVATIVES AND USES RELATED THERETO AMGEN INC (US) 2013-01-02 EP disclosed
US-20100069447-A1 BENZAMIDE DERIVATIVES AND USES RELATED THERETO AMGEN INC. 2010-03-18 US disclosed
US-7605289-B2 Benzamide derivatives and uses related thereto AMGEN, INC. (US) 2009-10-20 US disclosed
CN-101198584-A Benzamide derivatives and uses related thereto AMGEN INC (US) 2008-06-11 CN disclosed
EP-1904435-A2 BENZAMIDE DERIVATIVES AND USES RELATED THERETO Amgen Inc. (US) 2008-04-02 EP disclosed
US-20060293392-A1 Benzamide derivatives and uses related thereto AMGEN INC. 2006-12-28 US disclosed
WO-2006138508-A2 BENZAMIDE DERIVATIVES AND USES RELATED THERETO AMGEN INC. (US) 2006-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060293392-A1 Benzamide derivatives and uses related thereto GPR119, GLP1R, UGT2B7 ESR2 1392/4885HRH3 482/4885ELANE 2733/4885
US-20100069447-A1 BENZAMIDE DERIVATIVES AND USES RELATED THERETO GPR119, GLP1R, UGT2B7 ESR2 1392/4885HRH3 482/4885ELANE 2733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.